Підписатись
PIRES Geoffrey
PIRES Geoffrey
NYU Langone
Підтверджена електронна адреса в nyulangone.org
Назва
Посилання
Посилання
Рік
Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease
E Drummond, S Nayak, A Faustin, G Pires, RA Hickman, M Askenazi, ...
Acta neuropathologica 133, 933-954, 2017
1992017
Phosphorylated tau interactome in the human Alzheimer’s disease brain
E Drummond, G Pires, C MacMurray, M Askenazi, S Nayak, M Bourdon, ...
Brain 143 (9), 2803-2817, 2020
1912020
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
E Drummond, T Kavanagh, G Pires, M Marta-Ariza, E Kanshin, S Nayak, ...
Acta neuropathologica communications 10 (1), 53, 2022
552022
Isolation of amyloid plaques and neurofibrillary tangles from archived Alzheimer’s disease tissue using laser-capture microdissection for downstream proteomics
E Drummond, S Nayak, G Pires, B Ueberheide, T Wisniewski
Laser Capture Microdissection: Methods and Protocols, 319-334, 2018
442018
Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis
L Moro, D Simoneschi, E Kurz, AA Arbini, S Jang, N Guaragnella, ...
Nature cell biology 22 (9), 1130-1142, 2020
352020
Proteomic differences in the hippocampus and cortex of epilepsy brain tissue
G Pires, D Leitner, E Drummond, E Kanshin, S Nayak, M Askenazi, ...
Brain Communications 3 (2), fcab021, 2021
302021
Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies
G Pires, S McElligott, S Drusinsky, G Halliday, MC Potier, T Wisniewski, ...
Acta Neuropathologica Communications 7, 1-17, 2019
282019
Proteomics and transcriptomics of the hippocampus and cortex in SUDEP and high-risk SUDEP patients
DF Leitner, JD Mills, G Pires, A Faustin, E Drummond, E Kanshin, ...
Neurology 96 (21), e2639-e2652, 2021
272021
Compilation of reported protein changes in the brain in Alzheimer’s disease
M Askenazi, T Kavanagh, G Pires, B Ueberheide, T Wisniewski, ...
Nature Communications 14 (1), 4466, 2023
152023
Use of Affinity Purification–Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer’s Disease
G Pires, B Ueberheide, T Wisniewski, E Drummond
Alzheimer’s Disease: Methods and Protocols, 263-277, 2022
52022
CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder
A de Thonel, JK Ahlskog, K Daupin, V Dubreuil, J Berthelet, C Chaput, ...
Nature communications 13 (1), 7002, 2022
32022
It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseases
G Pires, E Drummond
Neural Regeneration Research 16 (11), 2211-2212, 2021
32021
Compilation of all known protein changes in the human Alzheimer's disease brain
M Askenazi, T Kavanagh, G Pires, B Ueberheide, T Wisniewski, ...
bioRxiv, 2023.04. 13.536828, 2023
22023
Proteomic similarities in Alzheimer’s disease and epilepsy brains highlight the important role of tau: Molecular and cell biology/endosomal‐lysosomal dysfunction
G Pires, D Leitner, E Kanshin, M Askenazi, D Friedman, O Devinsky, ...
Alzheimer's & Dementia 16, e046234, 2020
12020
The amyloid plaque proteome in different subtypes of Alzheimer’s disease: Human neuropathology: AD neuropathology
E Drummond, G Pires, E Kanshin, M Askenazi, B Ueberheide, ...
Alzheimer's & Dementia 16, e044973, 2020
12020
CBP/EP300-dependent acetylation and stabilization of HSF2 are compromised in the rare disorder, Rubinstein-Taybi syndrome
A de Thonel, JK Ahlskog, R Abane, G Pires, V Dubreuil, J Berthelet, ...
bioRxiv, 481457, 2018
12018
Similar brain proteomic signatures in Alzheimer’s disease and epilepsy
D Leitner, G Pires, T Kavanagh, E Kanshin, M Askenazi, B Ueberheide, ...
Acta Neuropathologica 147 (1), 1-17, 2024
2024
The pTau interactome in sporadic Alzheimer’s disease across APOE genotypes
M Thierry, J Ponce, MM Ariza, M Askenazi, A Faustin, D Leitner, G Pires, ...
Alzheimer's & Dementia 19, e073703, 2023
2023
Author Correction: CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder
A de Thonel, JK Ahlskog, K Daupin, V Dubreuil, J Berthelet, C Chaput, ...
nature communications 14, 2023
2023
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
GV Pires
Sorbonne Université; New York University. School of Medicine, 2021
2021
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20